Otsuka ICU Medical outlays $500m to expand US manufacturing footprint

The funds will support the construction of a new manufacturing facility and make significant upgrades to Otsuka ICU Medical's existing manufacturing site in Austin, Texas. The funds will support the construction of a new manufacturing facility and make significant upgrades to Otsuka ICU Medical's existing manufacturing site in Austin, Texas. Baxter provides 60% of the IV fluids used in the US, with critical shortages flaring after its North Carolina production facility was damaged during Hurricane Helene in 2025. Credit: Pressmaster/Shutterstock.com Otsuka ICU Medical is investing $500m into expanding its US-based IV manufacturing provision to improve long-term supply resiliency. The company,…

Source: Medical Device Network